Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

p3mutant CRE RE-TK hRluc(F)

Reporter construct of CRE response element/PMA

Catalog number RDB03460
Resource name p3mutant CRE RE-TK hRluc(F)
Alternative name 2060C164F
Clone info. mutant 3' CRE is cloned into the BglII site of phRL-TK, and the BglII site is killed by the cloning. The nucleotide sequence of the mutant 3' CRE is 5'-GATCCTGCAGTCATGCAGTCATGCAGTCAG-3'.
Comment The nucleotide sequence of the element was determined. Function of the inserted element has not been examined by the depositor.
Vector backbone phRL-TK (Plasmid)
Size of vector backbone 4.0 kb
Selectable markers Amp^r
Gene/insert name Artificial CRE response element/PMA, mutated synthesized
Depositor|Developer Yokoyama, Kazunari |
Other clones in our bank

External Database
Artificial CRE response element/PMA, mutated

            Reference sequence
              
             
            Remarks, protocol and/or map (pdf) RDB03460.pdf

            Distribution information

            Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
            Terms and conditions for distribution The RECIPIENT agrees to expressly describe the acknowledgement of the Gene Engineering Division, RIKEN BRC as the source of the BIOLOGICAL RESOURCE in any publication. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for-profit organization for a not-for-profit research.
            Additional terms and conditions:
            The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
            Ordering
            Order form [Credit Card Payment]  [Bank Transfer Payment]
            MTA, for use for not-for-profit academic purpose [Word]
            Please visit Information of Request for Distribution.[link] 
            提供案内 (日本国内) [open/close]

            提供条件 リソースを使用して論文を投稿する場合、理研BRC・遺伝子材料開発室から分譲された事を記載する。本件リソースは非営利機関にのみ提供し、非営利研究にのみ利用することができる。
            付加的提供条件:
            本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。
            提供依頼
            提供依頼書 [Word]
            提供同意書 (MTA, 非営利学術目的用)[Word]
            手続きの概要は、「提供申込みについて[link]」をご覧ください。

            Catalog # Resource name Shipping form Fee (non-profit org.)
            RDB03460 p3mutant CRE RE-TK hRluc(F) DNA solution

            Please review the QC test results indicated by check icon below as well as clone information before placing your order.

            How to cite this biological resource

            Materials & Methods section:

            The p3mutant CRE RE-TK hRluc(F) was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB03460).

            Reference section:

            Further references such as user reports and related articles (go to bottom)


            Tips

            Featured content


            QC test results

            RIKEN BRC has sequenced portions of this material for quality test.
            Please review the QC test results indicated by check icon as well as clone information before placing your order.

            Test sheet RDB13700_A5Jtp1.pdf check

            Nucleotide sequence of a portion of this resource (if available).

            Primer: TKproR
            Sequence file: RDB13700_A5Jta.seq check
            >03460_13700_A5Jt_TKpro_R_G03_21.ab1
                1 CCTAGTAAGT GTTTCGTTCT TCCCCTCCCC CCGCGTCAGA CAAACCCTAA CCACCGCTTA
               61 AGCGGCCCCC GCGAGGTCCG AAGACTCATT TAGATCCTGA CTGCATGACT GCATGACTGC
              121 AGGATCTGTC GAGCCATGTG AGCAAAAGGC CAGCAAAAGG CCAGGAACCG TAAAAAGGCC
              181 GCGTTGCTGG CGTTTTTCCA TAGGCTCCGC CCCCCTGACG AGCATCACAA AAATCGACGC
              241 TCAAGTCAGA GGTGGCGAAA CCCGACAGGA CTATAAAGAT ACCAGGCGTT TCCCCCTGGA
              301 AGCTCCCTCG TGCGCTCTCC TGTTCCGACC CTGCCGCTTA CCGGATACCT GTCCGCCTTT
              361 CTCCCTTCGG GAAGCGTGGC GCTTTCTCAT AGCTCACGCT GTAGGTATCT CAGTTCGGTG
              421 TAGGTCGTTC GCTCCAAGCT GGGCTGTGTG CACGAACCCC CCGTTCAGCC CGACCGCTGC
              481 GCCTTATCCG GTAACTATCG TCTTGAGTCC AACCCGGTAA GACACGACTT ATCGCCACTG
              541 GCAGCAGCCA CTGGTAACAG GATTAGCAGA GCGAGGTATG TAGGCGGTGC TACAGAGTTC
              601 TTGAAGTGGT GGCCTAACTA CGGCTACACT AGAAGAACAG TATTTGGTAT CTGCGCTCTG
              661 CTGAAGCCAG TTACCTTCGG AAAAAGAGTT GGTAGCTCTT GATCCGGCAA ACAAACCACC
              721 GCTGGTAGCG GTGGTTTTTT TGTTTGCAAG CAGCAGATTA CGCGCAGAAA AAAAGGATCT
              781 CAAGAAGATC CTTTGATCTT TTCTACGGGG TCTGACGCTC AGTGGAACGA AAACTCACGT
              841 TAAGGGATTT TGGTCATGAG ATTATCAAAA AAGGATCTTC ACCTAGATCC TTTTAAATTA
              901 AAAATGAAGT TTTTAAATCA ATCTAAAGTA TATATGAGTA AACTTGGGTC TGACAGTTTA
              961 CCAAATGCTT AATCAGTGAG GCACCCTATC TCAGCGATCT GTCTATTTCG TTCATCCATA
             1021 GTGCCTTGAC TTCCCCCGTT CGTGTTAGAA TACTAACTAT ACCGGCAAGG ACCTAACCAT
            1081 CTGGACCCCA GTGCCTTGCC GAG
            //
            Primer: pAxCALNL_F1
            Sequence file: RDB13700_A5Jtb.seq check
            >03460_13700_A5Jt_pAxCALNL_F1_H03_24.ab1
                1 AAAGTATCTT ATCATGTCTG CTCGAGCGGC CGCTCTAGAA TTACTGCTCG TTCTTCAGCA
               61 CGCGCTCCAC GAAGCTCTTG ATGTACTTAC CCATTTCATC TGGAGCGTCC TCCTGGCTGA
              121 AGTGGAGGCC CTTCACCTTC ACGAACTCGG TGTTAGGGAA CTTCTTAGCT CCCTCGACAA
              181 TAGCGTTGGA AAAGAACCCA GGGTCGGACT CGATGAACAT CTTAGGCAGA TCGTCGCTGG
              241 CCCGAAGGTA GGCGTTGTAG TTGCGGACAA TCTGGACGAC GTCGGGCTTG CCTCCCTTAA
              301 CGAGAGGGAT CTCGCGAGGC CAGGAGAGGG TAGGCCGTCT AACCTCGCCC TTCTCCTTGA
              361 ATGGCTCCAG GTAGGCAGCG AACTCCTCAG GCTCCAGTTT CCGCATGATC TTGCTTGGGA
              421 GCATGGTCTC GACGAAGAAG TTATTCTCAA GCACCATTTT CTCGCCCTCT TCGCTCTTGA
              481 TCAGGGCGAT ATCCTCCTCG ATGTCAGGCC ACTCGTCCCA GGACTCGATC ACGTCCACGA
              541 CACTCTCAGC ATGGACGATG GCCTTGATCT TGTCTTGGTG CTCGTAGGAG TAGTGAAAGG
              601 CCAGACAAGC CCCCCAGTCG TGGCCCACAA AGATGATTTT CTTTGGAAGG TTCAGCAGCT
              661 CGAACCAAGC GGTGAGGTAC TTGTAGTGAT CCAGGAGGCG ATATGAGCCA TTCCCGCTCT
              721 TGCCGGACTT ACCCATTCCG ATCAGATCAG GGATGATGCA TCTAGCCACG GGCTCGATGT
              781 GAGGCACGAC GTGCCTCCAC AGGTAGCTGG AGGCAGCGTT ACCATGCAGA AAAATCACGG
              841 CGTTCTCGGC GTGCTTCTCG GAATCATAGT AGTTGATGAA GGAGTCCAGC ACGTTCATTT
              901 GCTTGCAGCG AGCCCACCAC TGAGGCCCAG TGATCATGCG TTTGCGTTGC TCGGGGTCGT
              961 ACACCCTTGG AAAGCCATGG GTGGGCTAGC CCTATAGTGA GTCGTTATTT AAGTTACTCT
             1021 AGCCCTTTAG AGCTGGTAGT GGAACTTGCG CAGGTGGACA CTGATGCAGA GAAAGTAAAG
            1081 TGGCATTGTT CCAG
            //

            Please visit Sequencing and PCR primers for primer information.


            References

            Original, user report and related articles


            2023.11.08

            GNP_filter3_RDBDEP_html_231027.pl